Related Experiment Video
Updated: Jul 15, 2026

Peptide-based Identification of Functional Motifs and their Binding Partners
Published on: June 30, 2013
HLA-binding peptides as a therapeutic approach for chronic HIV infection
A Sette1, R Chesnut, B Livingston
1Epimmune Inc, 6555 Nacy Ridge Drive, Suite 100, San Diego, CA 92121, USA. asette@epimmune.com
Abstract:
Herein, we describe the Epimmune approach to prophylaxis and development of a multi-epitope vaccine for immunotherapy of HIV-1 infection. The central strategy of our program is to induce cellular immune responses, cytotoxic T-lymphocytes (CTL) and helper Tlymphocytes (HTL), specific for conserved epitopes from both structural and regulatory proteins of HIV-1. The HIV-1 derived and HLA-restricted CTL and HTL epitopes needed to design and construct the experimental vaccines are now known and allow for broad and non-ethnically biased coverage of the human population. The design optimization of an epitope-based DNA vaccine and evaluating methods for various DNA vaccine delivery technologies for possible use in clinical trials are addressed.
Related Concept Videos
Retrovirus Life Cycles
Inhibitors of Viral Protein Synthesis
Inhibitors of Virion Maturation and Assembly

